More than one-third of tumors sequenced carried a high mutation burden.
Survival disparities decreased after adjustment for health insurance and area-level socioeconomic status.
Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
Incidence rates decreased overall but increased among children and adolescents.
Researchers sought to determine the rates of VTE and major bleeding in patients with glioblastoma.
Researchers sought to determine whether CDKN2A deletion could predict a higher risk of VTE in patients with glioblastoma.
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
A 1:1 ratio of THC to CBD proved superior to a 4:1 ratio.
Therapy intensification with carboplatin improved five-year event-free survival in children with high-risk group 3 medulloblastoma only.
While there is short-term excess mortality, cumulative survival is similar to the general population.
The benefit was restricted to patients with IDH1/2-mutant tumors.
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
There was no improvement in progression-free or overall survival with marizomib.
Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records.
Early radiotherapy may preserve visual acuity for certain children with sporadic optic pathway/hypothalamic gliomas.
The proportion of childhood medulloblastomas varied widely between countries, offsetting the low proportion of low-grade astrocytomas in several countries.
Investigators sought to determine the prevalence of weight gain and becoming overweight or obese and its association with hypothalamic-pituitary dysfunction in survivors of childhood brain cancer.